Axsome Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Axsome Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q2 2024.
  • Axsome Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$79.3M, a 18.1% decline year-over-year.
  • Axsome Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$309M, a 67.3% decline year-over-year.
  • Axsome Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$239M, a 27.8% decline from 2022.
  • Axsome Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$187M, a 43.5% decline from 2021.
  • Axsome Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$130M, a 26.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$309M -$79.3M -$12.2M -18.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$296M -$68.4M -$57.1M -509% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-05
Q4 2023 -$239M -$98.7M -$37.4M -61.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$202M -$62.2M -$17.4M -38.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$184M -$67.2M -$25.7M -62.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$159M -$11.2M +$28.4M +71.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-05
Q4 2022 -$187M -$61.2M -$27.3M -80.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$160M -$44.8M -$9.94M -28.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$150M -$41.4M -$9.15M -28.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$141M -$39.6M -$10.4M -35.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$130M -$34M -$4.81M -16.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 -$126M -$34.9M -$12M -52.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$114M -$32.3M -$14M -76.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$99.7M -$29.3M +$3.22M +9.93% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$103M -$29.2M -$4.36M -17.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$98.5M -$22.9M -$3.79M -19.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$94.8M -$18.3M -$4.56M -33.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$90.2M -$32.5M -$21.8M -205% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$68.3M -$24.8M -$15.2M -158% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$53.1M -$19.1M -$10.9M -131% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$42.3M -$13.8M -$5.48M -66.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$36.8M -$10.6M -$5.83M -121% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$31M -$9.6M -$2.17M -29.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$28.8M -$8.28M -$1.85M -28.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$27M -$8.28M -$1.2M -16.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$25.8M -$4.81M +$3.19M +39.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$28.9M -$7.43M -$102K -1.39% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$28.8M -$6.43M +$761K +10.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 -$29.6M -$7.08M -$272K -4% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 -$29.3M -$8M -$2.13M -36.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 -$27.2M -$7.33M -$3.96M -118% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$23.2M -$7.19M -$2.62M -57.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$20.6M -$6.81M -$4.68M -220% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$15.9M -$5.87M -$3.73M -174% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$12.2M -$3.36M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 -$4.58M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 -$2.13M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 -$2.14M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.